Chronic Graft-versus-Host Disease: How Can We Release Prometheus?

Lee, 2003, Chronic graft-versus-host disease, Biol Blood Marrow Transplant, 9, 215, 10.1053/bbmt.2003.50026

Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004

Shulman, 2006, Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group report, Biol Blood Marrow Transplant, 12, 31, 10.1016/j.bbmt.2005.10.023

Zhang, 2002, Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation, J Immunol, 168, 3088, 10.4049/jimmunol.168.6.3088

Daikeler, 2007, Autoimmunity following haematopoietic stem-cell transplantation, Best Pract Res Clin Haematol, 20, 349, 10.1016/j.beha.2006.09.008

Rezvani, 2003, Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation, Blood, 102, 2892, 10.1182/blood-2003-01-0150

Tivol, 2005, Emergent autoimmunity in graft-versus-host disease, Blood, 105, 4885, 10.1182/blood-2004-12-4980

Chen, 2007, Absence of regulatory T cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft versus host disease, Blood, 10.1182/blood-2007-05-091074

Parkman, 1989, Graft-versus-host disease: an alternative hypothesis, Immunol Today, 10, 362, 10.1016/0167-5699(89)90267-3

Fukushi, 1990, Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance, Proc Natl Acad Sci USA, 87, 6301, 10.1073/pnas.87.16.6301

Sakoda, 2007, Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease, Blood, 109, 1756, 10.1182/blood-2006-08-042853

Zhang, 2007, CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease, J Immunol, 179, 3305, 10.4049/jimmunol.179.5.3305

Zeiser, 2006, Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production, Blood, 108, 390, 10.1182/blood-2006-01-0329

Zhang, 2006, Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations, Blood, 107, 2993, 10.1182/blood-2005-09-3623

Anderson, 2005, Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ, Blood, 105, 2227, 10.1182/blood-2004-08-3032

Kaplan, 2004, Target antigens determine graft-versus-host disease phenotype, J Immunol, 173, 5467, 10.4049/jimmunol.173.9.5467

Miklos, 2004, Antibody responses to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors, Blood, 103, 353, 10.1182/blood-2003-03-0984

Miklos, 2005, Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, 105, 2973, 10.1182/blood-2004-09-3660

Zorn, 2004, Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation, J Exp Med, 199, 1133, 10.1084/jem.20031560

She, 2007, Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease, Biol Blood Marrow Transplant, 13, 386, 10.1016/j.bbmt.2006.12.441

Ratanatharathorn, 2003, Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody, Biol Blood Marrow Transplant, 9, 505, 10.1016/S1083-8791(03)00216-7

Cutler, 2006, Rituximab for steroid-refractory chronic graft-versus-host disease, Blood, 108, 756, 10.1182/blood-2006-01-0233

Zaja, 2007, Treatment of chronic GVHD with rituximab: a GITMO study, Bone Marrow Transplant, 40, 273, 10.1038/sj.bmt.1705725

Svegliati Baroni, 2007, Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease, Blood, 110, 237, 10.1182/blood-2007-01-071043

Svegliati Baroni, 2006, Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis, N Engl J Med, 354, 2667, 10.1056/NEJMoa052955

Fujita, 2007, Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+regulatory T cells, Blood, 10.1182/blood-2007-04-086470

Wilson, 2007, IL-13Rα2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice, J Clin Invest, 10.1172/JCI31546

Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J Clin Invest, 117, 524, 10.1172/JCI31487

Pesce, 2006, The IL-21 receptor augments Th2 effector function and alternative macrophage activation, J Clin Invest, 116, 2044, 10.1172/JCI27727

Swartz, 2006, Schistosoma mansoni infection in eosinophil lineage-ablated mice, Blood, 108, 2420, 10.1182/blood-2006-04-015933

Ramalingam, 2005, Exploiting worm and allergy models to understand Th2 cytokine biology, Curr Opin Allergy Clin Immunol, 5, 392, 10.1097/01.all.0000182542.30100.6f

Kaviratne, 2004, IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent, J Immunol, 173, 4020, 10.4049/jimmunol.173.6.4020

Wynn, 2004, Fibrotic disease and the T(H)1/T(H)2 paradigm, Nat Rev Immunol, 4, 583, 10.1038/nri1412

Hesse, 2004, The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells, J Immunol, 172, 3157, 10.4049/jimmunol.172.5.3157

Cutler, 2001, Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation. A meta-analysis, J Clin Oncol, 19, 3685, 10.1200/JCO.2001.19.16.3685

Ho, 2001, The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation, Blood, 98, 3192, 10.1182/blood.V98.12.3192

Tsoi, 1981, Specific suppressor cells in graft-versus-host tolerance of HLA-identical marrow transplantation, Nature, 292, 355, 10.1038/292355a0

Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol, 155, 1151, 10.4049/jimmunol.155.3.1151

Salomon, 2000, B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes, Immunity, 12, 431, 10.1016/S1074-7613(00)80195-8

Shevach, 2001, Control of T-cell activation by CD4+ CD25+ suppressor T cells, Immunol Rev, 182, 58, 10.1034/j.1600-065X.2001.1820104.x

Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490

Fontenot, 2003, Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells, Nat Immunol, 4, 330, 10.1038/ni904

Seddiki, 2006, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, J Exp Med, 203, 1693, 10.1084/jem.20060468

Liu, 2006, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, 203, 1701, 10.1084/jem.20060772

Deaglio, 2007, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J Exp Med, 204, 1257, 10.1084/jem.20062512

Yamaguchi, 2007, Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor, Immunity, 27, 145, 10.1016/j.immuni.2007.04.017

Ehrenstein, 2004, Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy, J Exp Med, 200, 277, 10.1084/jem.20040165

Viglietta, 2004, Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis, J Exp Med, 199, 971, 10.1084/jem.20031579

Miyara, 2005, Global natural regulatory T cell depletion in active systemic lupus erythematosus, J Immunol, 175, 8392, 10.4049/jimmunol.175.12.8392

Bennett, 2001, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, 27, 20, 10.1038/83713

Le Bras, 2006, IPEX and the role of Foxp3 in the development and function of human Tregs, J Clin Invest, 116, 1473, 10.1172/JCI28880

Taylor, 2001, CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade, J Exp Med, 193, 1311, 10.1084/jem.193.11.1311

Taylor, 2002, The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality, Blood, 99, 3493, 10.1182/blood.V99.10.3493

Cohen, 2002, CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease, J Exp Med, 196, 401, 10.1084/jem.20020090

Hoffmann, 2002, Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation, J Exp Med, 196, 389, 10.1084/jem.20020399

Jones, 2003, Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response, Biol Blood Marrow Transplant, 9, 243, 10.1053/bbmt.2003.50027

Taylor, 2004, L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection, Blood, 104, 3804, 10.1182/blood-2004-05-1850

Ermann, 2005, Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD, Blood, 105, 2220, 10.1182/blood-2004-05-2044

Nguyen, 2007, In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation, Blood, 109, 2649, 10.1182/blood-2006-08-044529

von Boehmer, 2005, Mechanisms of suppression by suppressor T cells, Nat Immunol, 6, 338, 10.1038/ni1180

Sharma, 2007, Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase, J Clin Invest, 10.1172/JCI31911

Rieger, 2006, Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD, Blood, 107, 1717, 10.1182/blood-2005-06-2529

Wysocki, 2005, Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease, Blood, 106, 3300, 10.1182/blood-2005-04-1632

Rezvani, 2006, High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT, Blood, 108, 1291, 10.1182/blood-2006-02-003996

Wolf, 2007, Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation, Transplantation, 83, 1107, 10.1097/01.tp.0000260140.04815.77

Mutis, 2005, The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions, Haematologica, 90, 1389

Olkinuora, 2007, T cell regeneration in pediatric allogeneic stem cell transplantation, Bone Marrow Transplant, 39, 149, 10.1038/sj.bmt.1705557

Anderson, 2004, Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease, Blood, 104, 1565, 10.1182/blood-2004-01-0328

Miura, 2004, Association of Foxp3 regulatory gene expression with graft-versus-host disease, Blood, 104, 2187, 10.1182/blood-2004-03-1040

Zorn, 2005, Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease, Blood, 106, 2903, 10.1182/blood-2005-03-1257

Clark, 2004, Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells, Blood, 103, 2410, 10.1182/blood-2003-06-2073

Sanchez, 2004, Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation, Br J Haematol, 126, 697, 10.1111/j.1365-2141.2004.05108.x

Meignin, 2005, Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation, Exp Hematol, 33, 894, 10.1016/j.exphem.2005.05.001

Arimoto, 2007, FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation, Int J Hematol, 85, 154, 10.1532/IJH97.06160

Nadal, 2007, Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, Leukemia, 21, 472, 10.1038/sj.leu.2404522

Setoguchi, 2005, Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, J Exp Med, 201, 723, 10.1084/jem.20041982

Giorgini, 2007, Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts, J Leuk Biol, 10.1189/jlb.0407227

Valencia, 2006, TNF downmodulates the function of human CD4+CD25hi T-regulatory cells, Blood, 108, 253, 10.1182/blood-2005-11-4567

Wang, 2006, A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice, Transplantation, 82, 1484, 10.1097/01.tp.0000246312.89689.17

Battaglia, 2005, Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells, Blood, 105, 4743, 10.1182/blood-2004-10-3932

Fozza, 2007, T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25- counterpart, Haematologica, 92, 206, 10.3324/haematol.10774

Xia, 2004, Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease, Biol Blood Marrow Transplant, 10, 748, 10.1016/j.bbmt.2004.07.004

Trenado, 2006, Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells, J Immunol, 176, 1266, 10.4049/jimmunol.176.2.1266

Yamazaki, 2006, Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity, Immunol Rev, 212, 314, 10.1111/j.0105-2896.2006.00422.x

Albert, 2005, Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation, Eur J Immunol, 35, 2598, 10.1002/eji.200526077

Siewert, 2007, Induction of organ-selective CD4+ regulatory T cell homing, Eur J Immunol, 37, 978, 10.1002/eji.200636575

Schwarz, 2007, Alteration of the migratory behavior of UV-induced regulatory T cells by tissue-specific dendritic cells, J Immunol, 178, 877, 10.4049/jimmunol.178.2.877

Battaglia, 2006, Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients, J Immunol, 177, 8338, 10.4049/jimmunol.177.12.8338

Coenen, 2006, Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells, Blood, 107, 1018, 10.1182/blood-2005-07-3032

Strauss, 2007, Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin, J Immunol, 178, 320, 10.4049/jimmunol.178.1.320

Coenen, 2007, Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4(+)CD25(+)FoxP3(+) T cells, Bone Marrow Transplant, 39, 537, 10.1038/sj.bmt.1705628

Jurado, 2007, Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease, Biol Blood Marrow Transplant, 13, 701, 10.1016/j.bbmt.2007.02.003

Johnston, 2005, Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease, Biol Blood Marrow Transplant, 11, 47, 10.1016/j.bbmt.2004.10.004

Lopez, 2005, Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease, Biol Blood Marrow Transplant, 11, 307, 10.1016/j.bbmt.2005.01.011

Koc, 2002, Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone, Blood, 100, 48, 10.1182/blood.V100.1.48

Greinix, 2006, Assessing the potential role of photopheresis in hematopoietic stem cell transplant, Bone Marrow Transplant, 38, 265, 10.1038/sj.bmt.1705440

Peritt, 2006, Potential mechanisms of photopheresis in hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 12, 7, 10.1016/j.bbmt.2005.11.005

Meloni, 2007, Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients, Transplant Proc, 39, 213, 10.1016/j.transproceed.2006.10.227

Fontenot, 2005, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nat Immunol, 6, 1142, 10.1038/ni1263

Zhang, 2005, Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells, Nat Med, 11, 1238, 10.1038/nm1312

Sereti, 2005, In vivo expansion of CD4 CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients, J Clin Invest, 115, 1839, 10.1172/JCI24307

Zorn, 2006, IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo, Blood, 108, 1571, 10.1182/blood-2006-02-004747